Sign
A Memorandum of Collaboration addressed to the Registrar, setting scope, governance and shared success measures.

A new statute, a new regulation, and an open call from the Federal Ministry of Health have aligned in a single window. The infrastructure to answer that call is what this proposal is about.
The Act
The Pharmacy Council of Nigeria Act 2022 made PCN all-encompassing over personnel, premises, practice and medicine dealers.
The Law
The Electronic Pharmacy Regulations 2026 are now in force, requiring traceability, prescription control and data governance.
The Invitation
At the launch, the Coordinating Minister called for partnership and investment, and urged technology companies to engage PCN directly.
The invitation, accepted
Sproxil is that partner — and every idea here is judged by three questions:
Its impact on Community Pharmacists (CPs).
On PCN at state level.
On the national practice of pharmacy.
Each idea is a self-contained programme with a clear owner at PCN and a measurable outcome. Open any card to zoom in — you can jump between ideas without returning here.
Choose an idea →
Make “is my pharmacist licensed?” a national habit.
Help the pharmacists doing the right thing shine.
MCPD that fits in a pocket.
Two minutes, not a dreaded form.
Inspection that respects your approval flow.
Bring the informal sector into the net.
These are the Registrar's own stated priorities in the PCN Strategic Plan 2022–2026, answered one by one.
Re-engineer the Registry for quality service
Verify pharmacists, premises and Community Pharmacists (CPs) on a clean, real-time register powered by AI data-matching.
Digitalise inspectorate activities to promote transparency
End-to-end mobile field audit that follows the committee-to-HQ approval flow.
Revitalise MCPD and the Tier-Accreditation pilot
WhatsApp micro-learning with AI video and quizzes, plus a structured vendor tier upskilling pathway.
Implement Good Pharmacy Practice
Public verification and positive reinforcement so patients expect licensed, in-good-standing pharmacists.
Complete the Coordinated Wholesale Centres and clean distribution
Product authentication and track-and-trace across the supply chain.
Engage development and implementing partners
Jointly pursue five aligned grants with PCN as anchor.
A neutral, sovereign rail that could sit beneath every regulatory workflow — designed to interoperate with NAFDAC, NHIA and NHMIS rather than replace them, and to power a National E-Pharmacy Platform if Nigeria chooses to stand one up.
Who uses it
Patients, Community Pharmacists (CPs) and PCN inspectors — meeting them on the channels they already use.
MedRail — the rail
The connective tissue: standards, events, intelligence and identity — designed to sit under every module a future platform would need.
Modules
Sovereign data
All records on in-country servers under Nigerian control. Nothing leaves Nigeria. NDPA-aligned. No vendor lock-in.
MedRail is built to interoperate with NAFDAC, NHIA and NHMIS — extending, never replacing, the systems Nigeria already relies on.
Reference architecture
Providers push events, payers pull evidence. One gateway, one identity, one interoperability core — with external authorities kept deliberately off-rail. Illustrative.
Illustrative reference architecture. Every event routes through the spine; external authorities remain off-rail.
Trust by design
All records on in-country servers under Nigerian control.
Every read and write is attributable and tamper-evident.
Least-privilege by design, from inspector to Registrar.
FHIR R4 and open APIs; portable data, portable partners.
Regulatory decisions stay with certified professionals.
Works on 2G, in a shop, in a village, on a bad day.
Three interactive demos you can try in the room. Sample data shown is illustrative.
Search a name or PCN number. See a licence come back in a second.
Open demoPost-visit patient messages, storefront badges, streaks and renewal nudges.
Open demoTwo-minute AI micro-lessons and quizzes, delivered where pharmacists already are.
Open demoFile an adverse-reaction report in a chat, not a dreaded form.
Open demoInspector → Committee → PCN HQ, one shared inspection through the approval flow.
Open demoA conservative pathway with a wallet crediting fees, never cash.
Open demoFive aligned grants we would pursue jointly, with PCN as the anchor institution. Sproxil brings the delivery track record; PCN brings the statutory home.
Advancing Global Health (Nigeria, Addendum D)
US Department of State
Typical size
0.5M – 250M USDDeadline
Statement of Interest due 31 July 2026What it funds
Medicine quality, e-pharmacy, digital health systems.Global Health EDCTP3 — pharmacovigilance / digital / AI topics
European Union
Typical size
~2 – 2.25M EUR per grantDeadline
~September 2026What it funds
PV and digital regulatory platforms. Requires an Africa–Europe consortium.Fleming Fund — AMR & use surveillance
UK Government
Typical size
Several million GBP over 12–24 monthsDeadline
Next tender (currently held by MSH)What it funds
Dispensing-data surveillance and stewardship. Partner-in or next round.Grand Challenges Africa
Science for Africa Foundation
Typical size
Seed ~100k USD → scale-up to 1M USDDeadline
Periodic windowsWhat it funds
African-led health innovation, including AMR.Grand Challenges Nigeria
Office of the Vice President & Ministry of Innovation
Typical size
Up to 60M NGN per grantDeadline
Next call for proposalsWhat it funds
Nigerian-led, scalable health innovation.Not a pilot. A phased national programme, sequenced for equitable geopolitical representation and anchored on the drug markets PCN already prioritises.
The three high-volume drug markets PCN already prioritises.
Bringing in all six geopolitical zones — equitable by design.
Delivered on PCN's existing zonal and state-office network — not a parallel apparatus.
We start big, and we start fair.
Addressed to the Registrar and Chief Executive Officer, Pharm. Ibrahim Babashehu Ahmed, FPSN.
A Memorandum of Collaboration addressed to the Registrar, setting scope, governance and shared success measures.
Phase 1 across the workstreams PCN chooses — registry, inspectorate, pharmacovigilance, learning, or verification.
PCN owns the data and the mandate. Sproxil builds and operates under PCN authority, on sovereign infrastructure.